RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Tranzyme Pharma today announced that Anthony J. Senagore, MD, MBA, MS, FACS, Vice President, Research & Education of Spectrum Health and Professor of Surgery, Michigan State University/CHM, will present results from the successful study of ghrelin agonist TZP-101 for the management of postoperative ileus (POI) at the upcoming 2009 Annual Meeting of the American Society of Colon and Rectal Surgeons (ASCRS) being held from May 2-6, 2009. Dr. Senagore’s presentation will take place on Wednesday, May 6, 2009 at 4:50 p.m. EST in the Atlantic Ballroom of the Westin Diplomat Hotel in Hollywood, FL.
